Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schollmeyer

Showing results (11-20 of 288) with videos related to

Pageof 29
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|September 15, 1996
[Pneumocystis carinii and aspergillus pneumonia in immunosuppression in rapidly progressing glomerulonephritis of the anti-glomerular basement membrane type]M Späth, P Schollmeyer
Klinische Wochenschrift|March 1, 1973
Metabolic adaptation in muscle of phosphorylase deficiency (McArdle's disease)?J Nolte, P Schollmeyer
Cardiology|January 1, 1985
Metabolic consequences of long-term thiazide-based antihypertensive treatment of renal hypertensionH Schiffl, P Schollmeyer
MMW, Munchener Medizinische Wochenschrift|November 3, 1978
[The therapeutic importance of cimetidine (Tagamet) (author's transl)]E Voget, P Schollmeyer
Klinische Wochenschrift|January 4, 1990
Morbidity of patients with analgesic-associated nephropathy on regular dialysis treatment and after renal transplantationC Ballé, P Schollmeyer
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1989
Evaluation of urate renal handling in humansS Rauer, P Schollmeyer
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1985
Clinical efficacy and safety of long-term diuretic treatment in renal parenchymal hypertensionH Schiffl, P Schollmeyer
Clinical Nephrology|January 1, 1988
The immune status of the uremic patient: hemodialysis vs CAPDP Schollmeyer, F Bozkurt
APMIS. Supplementum|January 1, 1990
Ciclosporin in the treatment of Wegener's granulomatosis (WG) and related diseasesP Schollmeyer, W Grotz
British Journal of Pharmacology|July 1, 1989
Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidneyL C Rump, P Schollmeyer
Pageof 29

Showing results (11-20 of 288) with videos related to

Sort By:
Pageof 29
Medizinische Klinik (Munich, Germany : 1983)|September 15, 1996
[Pneumocystis carinii and aspergillus pneumonia in immunosuppression in rapidly progressing glomerulonephritis of the anti-glomerular basement membrane type]M Späth, P Schollmeyer
Klinische Wochenschrift|March 1, 1973
Metabolic adaptation in muscle of phosphorylase deficiency (McArdle's disease)?J Nolte, P Schollmeyer
Cardiology|January 1, 1985
Metabolic consequences of long-term thiazide-based antihypertensive treatment of renal hypertensionH Schiffl, P Schollmeyer
MMW, Munchener Medizinische Wochenschrift|November 3, 1978
[The therapeutic importance of cimetidine (Tagamet) (author's transl)]E Voget, P Schollmeyer
Klinische Wochenschrift|January 4, 1990
Morbidity of patients with analgesic-associated nephropathy on regular dialysis treatment and after renal transplantationC Ballé, P Schollmeyer
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1989
Evaluation of urate renal handling in humansS Rauer, P Schollmeyer
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1985
Clinical efficacy and safety of long-term diuretic treatment in renal parenchymal hypertensionH Schiffl, P Schollmeyer
Clinical Nephrology|January 1, 1988
The immune status of the uremic patient: hemodialysis vs CAPDP Schollmeyer, F Bozkurt
APMIS. Supplementum|January 1, 1990
Ciclosporin in the treatment of Wegener's granulomatosis (WG) and related diseasesP Schollmeyer, W Grotz
British Journal of Pharmacology|July 1, 1989
Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidneyL C Rump, P Schollmeyer
Pageof 29